Poster zum Thema "Headache in children and adolescents "

Zurück
  • P163
Subjective Tinnitus in Pediatric and Adolescent Migraine Versus Other Primary Headaches – a Prospective, Comparative Study
  • Tal Eidlitz Markus (Tel Aviv/ IL; Petach Tikva/ IL)
  • P226
Characterising the extended phenotype of paediatric migraine: a prospective study
  • P227
Sleep Disorders in Pediatric Migraine: a questionnaire-based study
  • P228
Interictal cognitive performance in children and adolescents with primary headache: a narrative review
  • P229
Severe abrupt (thunderclap) non-traumatic headache at the pediatric emergency department
  • P230
Cutaneous allodynia in pediatric and adolescent patients and their mothers – a comparative study
  • P232
Long-term effects of pandemic of Covid-19 on clinical features and psychological symptoms in adolescents with migraine
  • P233
From the new diagnostic criteria to Covid-19 pandemic passing throught the placebo effect. What have we learned in the management of pediatric migraine over the past 5 years? The opinion of Italian pediatric headache centers
  • P234
The influence of anxiety and depression on headache in adolescent migraineurs: A case-control study
  • P235
Abnormal eye movements in a girl with Vestibular migraine: a case report and review of the literature
  • P236
Allodynia and muscle sensitization of cervical muscles are not associated with neck range of motion in children and adolescents diagnosed with migraine
  • P237
Neck-Tongue syndrome: an underrecognized and peculiar form of headache
  • P238
Does symptomatic treatment help children and adolescents with chronic migraine?
  • P239
Angelman syndrome and cyclic vomiting syndrome: a new potential association – Not all the vomiting are only vomiting!
  • P240
Clinical characteristics of children and adolescents with primary and secondary headaches in the tertiary-level of a public hospital in Brazil
  • P241
Sars-Cov-2 and Headache in Children and adolescents
  • P49
Use of anti-CGRP monoclonal antibodies in pediatric migraine: first evaluations of a phase 3, randomized, double-blind, placebo-controlled study